$SEEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SEELOS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SEELOS THERAPEUTICS, INC.. Get notifications about new insider transactions in SEELOS THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | SEEL | SEELOS THERAPEUTIC ... | Mehra Raj | See Remarks | Option Exercise | A | 4.31 | 1,150,000 | 4,956,500 | 1,150,000 | |
May 15 2020 | SEEL | SEELOS THERAPEUTIC ... | Dunn Judith | Director | Option Exercise | A | 0.97 | 16,000 | 15,520 | 16,000 | |
May 15 2020 | SEEL | SEELOS THERAPEUTIC ... | Dunn Judith | Director | Option Exercise | A | 0.97 | 24,000 | 23,280 | 24,000 | |
Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Pascoe Richard W | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Lian Brian | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | Mehra Raj | See Remarks | Option Exercise | A | 1.42 | 731,000 | 1,038,020 | 731,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Smith Robin L | Director | Option Exercise | A | 2.33 | 24,000 | 55,920 | 24,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Lian Brian | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Lian Brian | Director | Option Exercise | A | 2.33 | 24,000 | 55,920 | 24,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 2.33 | 24,000 | 55,920 | 24,000 | |
Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | Pascoe Richard W | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
Jan 28 2019 | APRI | SEELOS THERAPEUTIC ... | Mehra Raj | See Remarks | Grant | A | 0.00 | 3,081,546 | 0 | 3,081,546 | 0 to 3.1 M |
Jan 24 2019 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 0.23 | 44,810 | 10,149 | 155,396 | 200.2 K to 155.4 K (-22.38 %) |
Jan 24 2019 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Payment of Exercise | F | 0.23 | 32,705 | 7,408 | 100,158 | 132.9 K to 100.2 K (-24.62 %) |
Nov 30 2018 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Payment of Exercise | F | 0.31 | 12,968 | 3,968 | 132,863 | 145.8 K to 132.9 K (-8.89 %) |
Nov 30 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 0.31 | 17,290 | 5,291 | 200,206 | 217.5 K to 200.2 K (-7.95 %) |
Sep 04 2018 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | Payment of Exercise | F | 0.33 | 43,225 | 14,264 | 115,891 | 159.1 K to 115.9 K (-27.17 %) | |
Sep 04 2018 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | Buy | M | 0.00 | 81,775 | 0 | 159,116 | 77.3 K to 159.1 K (+105.73 %) | |
Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 653,409 | |
Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 653,409 | |
Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 0 | |
Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 0 | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Option Exercise | A | 2.11 | 60,000 | 126,600 | 60,000 | |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Payment of Exercise | F | 1.84 | 5,485 | 10,092 | 159,116 | 164.6 K to 159.1 K (-3.33 %) |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Option Exercise | A | 2.11 | 60,000 | 126,600 | 60,000 | |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Payment of Exercise | F | 1.84 | 2,194 | 4,037 | 145,831 | 148 K to 145.8 K (-1.48 %) |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Option Exercise | A | 2.11 | 245,000 | 516,950 | 245,000 | |
Jan 03 2018 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 1.84 | 7,679 | 14,129 | 217,496 | 225.2 K to 217.5 K (-3.41 %) |
Sep 07 2017 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Payment of Exercise | F | 1.56 | 14,093 | 21,985 | 148,025 | 162.1 K to 148 K (-8.69 %) |
Sep 07 2017 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Payment of Exercise | F | 1.56 | 14,093 | 21,985 | 164,601 | 178.7 K to 164.6 K (-7.89 %) |
Sep 07 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 1.56 | 18,790 | 29,312 | 225,175 | 244 K to 225.2 K (-7.70 %) |
Sep 01 2017 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 8.80 | 2,835 | 24,948 | 672,453 | |
Sep 01 2017 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 1.63 | 6,104 | 9,950 | 1,447,906 | 1.4 M to 1.4 M (+0.42 %) |
Jun 05 2017 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Grant | A | 0.00 | 75,000 | 0 | 162,118 | 87.1 K to 162.1 K (+86.09 %) |
Jun 05 2017 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Grant | A | 0.00 | 75,000 | 0 | 178,694 | 103.7 K to 178.7 K (+72.33 %) |
Jun 05 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 100,000 | 0 | 243,965 | 144 K to 244 K (+69.46 %) |
Mar 24 2017 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Payment of Exercise | F | 2.78 | 1,495 | 4,156 | 103,694 | 105.2 K to 103.7 K (-1.42 %) |
Mar 24 2017 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Payment of Exercise | F | 2.78 | 831 | 2,310 | 87,118 | 87.9 K to 87.1 K (-0.94 %) |
Mar 24 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Payment of Exercise | F | 2.78 | 3,712 | 10,319 | 143,965 | 147.7 K to 144 K (-2.51 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 11,250 | 0 | 15,373 | 4.1 K to 15.4 K (+272.86 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Grant | A | 0.00 | 75,000 | 0 | 87,949 | 12.9 K to 87.9 K (+579.20 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.00 | 11,250 | 0 | 13,854 | 2.6 K to 13.9 K (+432.03 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 100,000 | 0 | 147,677 | 47.7 K to 147.7 K (+209.74 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 24,575 | 9.6 K to 24.6 K (+156.66 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.00 | 11,250 | 0 | 16,160 | 4.9 K to 16.2 K (+229.12 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Grant | A | 0.00 | 11,250 | 0 | 16,955 | 5.7 K to 17 K (+197.20 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Grant | A | 0.00 | 75,000 | 0 | 105,189 | 30.2 K to 105.2 K (+248.43 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.34 | 16,997 | 5,750 | 95,746 | 78.7 K to 95.7 K (+21.58 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Grant | A | 0.34 | 10,161 | 3,437 | 57,045 | 46.9 K to 57 K (+21.67 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.34 | 9,607 | 3,250 | 49,093 | 39.5 K to 49.1 K (+24.33 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.34 | 10,715 | 3,625 | 26,039 | 15.3 K to 26 K (+69.92 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.34 | 8,868 | 3,000 | 41,228 | 32.4 K to 41.2 K (+27.40 %) |
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.40 | 9,074 | 3,625 | 15,324 | 6.3 K to 15.3 K (+145.18 %) |
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Grant | A | 0.40 | 8,605 | 3,438 | 46,884 | 38.3 K to 46.9 K (+22.48 %) |
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.40 | 14,393 | 5,750 | 78,749 | 64.4 K to 78.7 K (+22.36 %) |
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.40 | 8,136 | 3,250 | 39,486 | 31.4 K to 39.5 K (+25.95 %) |
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.40 | 7,510 | 3,000 | 32,360 | 24.9 K to 32.4 K (+30.22 %) |
May 20 2016 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | VP Finance & CAO | Grant | A | 0.00 | 50,000 | 0 | 34,594 | -15,406 to 34.6 K (-324.55 %) |
May 20 2016 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Grant | A | 0.00 | 100,000 | 0 | 129,496 | 29.5 K to 129.5 K (+339.03 %) |
May 20 2016 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Grant | A | 0.00 | 250,000 | 0 | 301,891 | 51.9 K to 301.9 K (+481.78 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.58 | 8,621 | 5,000 | 64,356 | 55.7 K to 64.4 K (+15.47 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.58 | 4,850 | 2,813 | 31,350 | 26.5 K to 31.4 K (+18.30 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Grant | A | 0.58 | 5,927 | 3,438 | 38,279 | 32.4 K to 38.3 K (+18.32 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.58 | 4,850 | 2,813 | 24,850 | 20 K to 24.9 K (+24.25 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.58 | 6,250 | 3,625 | 6,250 | 0 to 6.3 K |
Apr 05 2016 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Option Exercise | A | 0.57 | 165,000 | 94,050 | 165,000 | |
Apr 27 2016 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Grant | A | 0.00 | 250,000 | 0 | 301,891 | 51.9 K to 301.9 K (+481.78 %) |
Apr 27 2016 | APRI | APRICUS BIOSCIENCE ... | Morton Neil | SVP, Chief Business ... | Grant | A | 0.00 | 100,000 | 0 | 129,496 | 29.5 K to 129.5 K (+339.03 %) |
Apr 27 2016 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | VP Finance & CAO | Grant | A | 0.00 | 50,000 | 0 | 84,594 | 34.6 K to 84.6 K (+144.53 %) |
Apr 27 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 350,000 | 0 | 476,778 | 126.8 K to 476.8 K (+276.07 %) |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Option Exercise | A | 1.11 | 200,000 | 222,000 | 200,000 | |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | SVP, Chief Developm ... | Grant | A | 0.00 | 41,891 | 0 | 51,891 | 10 K to 51.9 K (+418.91 %) |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Troupin Barbara | SVP, Chief Medical ... | Option Exercise | A | 1.11 | 200,000 | 222,000 | 200,000 | |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Troupin Barbara | SVP, Chief Medical ... | Grant | A | 0.00 | 43,918 | 0 | 43,918 | 0 to 43.9 K |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | VP Finance & CAO | Option Exercise | A | 1.11 | 85,000 | 94,350 | 85,000 | |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | VP Finance & CAO | Grant | A | 0.00 | 34,594 | 0 | 34,594 | 0 to 34.6 K |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Option Exercise | A | 1.11 | 500,000 | 555,000 | 500,000 | |
Mar 17 2016 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | CEO & Secretary | Grant | A | 0.00 | 79,778 | 0 | 126,778 | 47 K to 126.8 K (+169.74 %) |
Mar 07 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.88 | 3,323,864 | 2,925,000 | 6,724,525 | |
Mar 07 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 0.88 | 6,647,728 | 5,850,001 | 14,479,053 | 7.8 M to 14.5 M (+84.89 %) |
Jan 14 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.88 | 653,409 | 575,000 | 3,400,661 | |
Jan 14 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 0.88 | 1,306,819 | 1,150,001 | 7,831,324 | 6.5 M to 7.8 M (+20.03 %) |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | Gillespie Deirdre | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.97 | 50,000 | 48,500 | 50,000 | |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Jan 30 2015 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | VP Finance & CAO | Option Exercise | A | 1.43 | 30,000 | 42,900 | 30,000 | |
Jan 30 2015 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Option Exercise | A | 1.43 | 150,000 | 214,500 | 150,000 | |
Jan 30 2015 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Option Exercise | A | 1.43 | 300,000 | 429,000 | 300,000 | |
Jan 30 2015 | APRI | APRICUS BIOSCIENCE ... | Troupin Barbara | Chief Medical Offic ... | Option Exercise | A | 1.43 | 50,000 | 71,500 | 50,000 | |
Jan 30 2015 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | Chief Development O ... | Option Exercise | A | 1.43 | 50,000 | 71,500 | 50,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.20 | 50,000 | 60,000 | 50,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 1.20 | 25,000 | 30,000 | 25,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 1.20 | 25,000 | 30,000 | 25,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | Gillespie Deirdre | Director | Option Exercise | A | 1.20 | 25,000 | 30,000 | 25,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | A | 1.20 | 25,000 | 30,000 | 25,000 | |
Jan 26 2015 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 1.20 | 25,000 | 30,000 | 25,000 | |
Jan 12 2015 | APRI | APRICUS BIOSCIENCE ... | Bovenizer Catherine | SVP Finance & CAO | Option Exercise | A | 1.52 | 150,000 | 228,000 | 150,000 | |
Dec 30 2014 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | Chief Development O ... | Buy | P | 1.05 | 10,000 | 10,481 | 10,000 | 0 to 10 K |
Dec 22 2014 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Buy | P | 1.02 | 10,000 | 10,217 | 47,000 | 37 K to 47 K (+27.03 %) |
Dec 15 2014 | APRI | APRICUS BIOSCIENCE ... | Troupin Barbara | Chief Medical Offic ... | Option Exercise | A | 1.16 | 300,000 | 348,000 | 300,000 | |
Dec 02 2014 | APRI | APRICUS BIOSCIENCE ... | Dorsey Brian | Chief Development O ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 | |
Oct 24 2014 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Buy | P | 1.59 | 18,200 | 28,998 | 26,500 | 8.3 K to 26.5 K (+219.28 %) |
Oct 24 2014 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Buy | P | 1.52 | 8,300 | 12,651 | 8,300 | 0 to 8.3 K |
Oct 24 2014 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Buy | P | 1.50 | 3,500 | 5,250 | 32,352 | 28.9 K to 32.4 K (+12.13 %) |
Oct 24 2014 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Buy | P | 1.52 | 20,000 | 30,364 | 20,000 | 0 to 20 K |
Oct 24 2014 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Buy | P | 1.51 | 12,000 | 18,120 | 37,000 | 25 K to 37 K (+48.00 %) |
Aug 12 2014 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 1.95 | 85,000 | 165,750 | 85,000 | |
Mar 11 2014 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 2.40 | 100,000 | 240,000 | 100,000 | |
Feb 24 2014 | APRI | APRICUS BIOSCIENCE ... | Cox Edward M. | VP of Business Deve ... | Option Exercise | A | 2.38 | 31,950 | 76,041 | 31,950 | |
Feb 24 2014 | APRI | APRICUS BIOSCIENCE ... | Martin Steven Robert | Senior VP & CFO | Option Exercise | A | 2.38 | 71,000 | 168,980 | 71,000 | |
Feb 24 2014 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Option Exercise | A | 2.38 | 177,500 | 422,450 | 177,500 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Martin Steven Robert | Senior VP & CFO | Option Exercise | A | 2.36 | 75,000 | 177,000 | 75,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.36 | 34,000 | 80,240 | 34,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Oppenheim Leonard A | Director | Option Exercise | A | 2.36 | 9,000 | 21,240 | 9,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Option Exercise | A | 2.36 | 157,808 | 372,427 | 157,808 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 25,000 | 35 K to 25 K (-28.57 %) |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Gillespie Deirdre | Director | Option Exercise | A | 2.36 | 9,000 | 21,240 | 9,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | A | 2.36 | 9,000 | 21,240 | 9,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | Cox Edward M. | VP of Business Deve ... | Option Exercise | A | 2.36 | 50,000 | 118,000 | 50,000 | |
Feb 10 2014 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 2.36 | 9,000 | 21,240 | 9,000 | |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 2.59 | 16,000 | 41,440 | 16,000 | |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.59 | 16,000 | 41,440 | 16,000 | |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | A | 2.59 | 16,000 | 41,440 | 16,000 | |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | Oppenheim Leonard A | Director | Option Exercise | A | 2.59 | 16,000 | 41,440 | 16,000 | |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | Oppenheim Leonard A | Director | Sell | S | 2.49 | 15,212 | 37,928 | 20,449 | 35.7 K to 20.4 K (-42.66 %) |
Jan 06 2014 | APRI | APRICUS BIOSCIENCE ... | Gillespie Deirdre | Director | Option Exercise | A | 2.59 | 16,000 | 41,440 | 16,000 | |
Dec 27 2013 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Sell | S | 2.55 | 17,184 | 43,819 | 55,735 | 72.9 K to 55.7 K (-23.57 %) |
Jun 21 2013 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Sell | S | 2.52 | 2,864 | 7,217 | 72,919 | 75.8 K to 72.9 K (-3.78 %) |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Option Exercise | P | 3.40 | 5,000 | 17,000 | 5,000 | |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Ray Rusty | Director | Buy | P | 2.85 | 5,000 | 14,250 | 28,852 | 23.9 K to 28.9 K (+20.96 %) |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Option Exercise | P | 3.40 | 35,000 | 119,000 | 35,000 | |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Pascoe Richard W | Chief Executive Off ... | Buy | P | 2.85 | 35,000 | 99,750 | 35,000 | 0 to 35 K |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Martin Steven Robert | Senior VP & CFO | Option Exercise | P | 3.40 | 20,000 | 68,000 | 20,000 | |
May 24 2013 | APRI | APRICUS BIOSCIENCE ... | Martin Steven Robert | Senior VP & CFO | Buy | P | 2.85 | 20,000 | 57,000 | 20,000 | 0 to 20 K |
May 23 2013 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Sell | S | 3.36 | 2,864 | 9,613 | 75,783 | 78.6 K to 75.8 K (-3.64 %) |
Apr 22 2013 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Sell | S | 2.63 | 2,864 | 7,524 | 78,647 | 81.5 K to 78.6 K (-3.51 %) |
Apr 01 2013 | APRI | APRICUS BIOSCIENCE ... | Martin Steven Robert | Senior VP & CFO | Option Exercise | A | 2.68 | 1,371 | 3,674 | 1,371 | |
Mar 21 2013 | APRI | APRICUS BIOSCIENCE ... | XANTHOPOULOS KLEANTHIS G | Director | Sell | S | 2.50 | 2,864 | 7,160 | 81,511 | 84.4 K to 81.5 K (-3.39 %) |